Intelligent Bio Solutions Inc. financial data

Symbol
INBS on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
135 W 41 St St,, Floor 5, New York, NY
State of incorporation
DE
Fiscal year end
June 30
Former names
GBS Inc. (to 10/18/2022), Glucose Biosensor Systems (Greater China) Holdings, Inc. (to 9/19/2019)
Latest financial report
10-Q - Q4 2024 - Feb 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 144 % +122%
Quick Ratio 14.6 % -13.7%
Debt-to-equity 73.1 % -56.9%
Return On Equity -146 % +61.9%
Return On Assets -83.5 % +39.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.28M shares +146%
Common Stock, Shares, Outstanding 4.81M shares +226%
Entity Public Float 5.99M USD +63.3%
Common Stock, Value, Issued 48.1K USD +226%
Weighted Average Number of Shares Outstanding, Basic 4.54M shares +378%
Weighted Average Number of Shares Outstanding, Diluted 4.54M shares +378%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 741K USD -19.2%
Revenue from Contract with Customer, Excluding Assessed Tax 3.03M USD +41.1%
Cost of Revenue 1.47M USD -31.9%
General and Administrative Expense 8.85M USD +4.26%
Operating Income (Loss) -10.8M USD +21.9%
Nonoperating Income (Expense) 21.5K USD -93.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -6.35M USD -373%
Net Income (Loss) Attributable to Parent -10.7M USD +20.2%
Earnings Per Share, Basic 6.97 USD/shares +75.8%
Earnings Per Share, Diluted 6.97 USD/shares +75.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.24M USD +100%
Accounts Receivable, after Allowance for Credit Loss, Current 266K USD +1.24%
Inventory, Net 701K USD -25.6%
Other Assets, Current 349K USD +5.15%
Assets, Current 4.06M USD +37.9%
Property, Plant and Equipment, Net 537K USD -9.15%
Operating Lease, Right-of-Use Asset 183K USD -57.8%
Intangible Assets, Net (Excluding Goodwill) 3.9M USD -19.7%
Goodwill 3.8M USD
Assets 8.68M USD -1.62%
Employee-related Liabilities, Current 417K USD +13.6%
Accrued Liabilities, Current 607K USD -21.9%
Liabilities, Current 4.4M USD -15.1%
Operating Lease, Liability, Noncurrent 14.5K USD -93.6%
Liabilities 4.48M USD -21%
Accumulated Other Comprehensive Income (Loss), Net of Tax -639K USD -23.4%
Retained Earnings (Accumulated Deficit) -56.9M USD -23.2%
Stockholders' Equity Attributable to Parent 4.37M USD +33.1%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 4.2M USD +33.3%
Liabilities and Equity 8.68M USD -1.62%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.39M USD -82%
Net Cash Provided by (Used in) Financing Activities 42.5K USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 4.81M shares +226%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.31M USD -71.4%
Deferred Tax Assets, Valuation Allowance 10.4M USD +9.35%
Deferred Tax Assets, Gross 10.4M USD +9.35%
Operating Lease, Liability 310K USD -39.5%
Depreciation 6.41K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -10.8M USD +19%
Lessee, Operating Lease, Liability, to be Paid 335K USD -43.8%
Property, Plant and Equipment, Gross 627K USD -13.4%
Operating Lease, Liability, Current 206K USD -17.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 83.5K USD -73%
Lessee, Operating Lease, Liability, to be Paid, Year One 88K USD -59.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 25.1K USD -70.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 81.1K USD
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 61.9M USD +23.7%
Amortization of Intangible Assets 953K USD +1.77%
Depreciation, Depletion and Amortization 242K USD -2.41%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%